Ebitda Cambio Fecha
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amgen USD 5.8B 1.25B 2026-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 222.32M 76.27M 2026-06
Cytokinetics USD -160.3M 9.02M 2026-06
Daiichi Sankyo JPY 116.06B 14.46B 2026-06
Gilead Sciences USD -9.31B 12.82B 2026-06
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Novartis USD 8.62B 2.14B 2026-09
Pfizer USD 6.36B 350M 2026-09
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Roche Holding CHF 13.43B 744M 2026-06
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
TG Therapeutics USD 26.9M 1.21M 2026-06
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06
Xencor USD 25.1M 59.73M 2026-09